TCL Archive Conversation with The Cancer Letter: Scott Soefje: “These are Life-Saving Drugs. I’m Not Going To Stop Treating Patients, Right?” October 3, 2014
TCL Archive Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival November 29, 2013
TCL Archive Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial. June 15, 2007
TCL Archive NCI’s Plan to Limit Growth of Core Grants Prompts Smaller Cancer Centers to Cry Foul May 11, 2012
